Sports Medicine and Science, KyungHee University, 1732 Deogyeong-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 17104, Republic of Korea.
Support Care Cancer. 2021 Jun;29(6):2863-2873. doi: 10.1007/s00520-020-05939-3. Epub 2021 Jan 6.
The purpose of this meta-analysis is to investigate the effectiveness of exercise interventions in patients with lung cancer (LC) during chemotherapy regarding physiological and psychological outcomes.
Databases including MEDLINE and EMBASE were used to find relevant randomized controlled trails that explored outcomes of exercise interventions for patients with LC during chemotherapy up to June 2020. Effect sizes were calculated by standardized mean difference statistics.
Six studies were included that involved 244 participants with average age of 65 years. Patients with LC participating in exercise interventions during chemotherapy had significantly increased strength, forced expired volume, and quality of life as well as significantly decreased pain. Effective exercise intervention characteristics were combined aerobic and resistance exercise, performance more than 5 times a week, moderate to vigorous intensity, and 1-h sessions.
Supervised participation in exercise improves strength, forced expired volume, and quality of life and relieves pain and depression during chemotherapy.
本荟萃分析旨在调查化疗期间肺癌(LC)患者运动干预在生理和心理结局方面的有效性。
使用 MEDLINE 和 EMBASE 等数据库,查找截至 2020 年 6 月探索化疗期间 LC 患者运动干预结局的相关随机对照试验。采用标准化均数差统计学计算效应量。
纳入 6 项研究,共 244 名平均年龄为 65 岁的患者。化疗期间接受运动干预的 LC 患者的力量、用力呼气量和生活质量显著提高,疼痛显著减轻。有效的运动干预特征是结合有氧运动和抗阻运动、每周运动 5 次以上、中等至剧烈强度以及每次 1 小时。
在化疗期间,监督下的运动参与可改善力量、用力呼气量和生活质量,并缓解疼痛和抑郁。